中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
7期
198-199
,共2页
神经衰弱%阿普唑仑%天麻素
神經衰弱%阿普唑崙%天痳素
신경쇠약%아보서륜%천마소
Neurasthenia%Alprazolam%Gastrodin
目的：探究神经衰弱患者采用阿普唑仑和天麻素的综合治疗的方法和效果。方法选取2013年5月～2014年7月收治的38例神经衰弱患者进行治疗，随机分组，实验组21例患者阿普唑仑和天麻素的综合治疗，对照组17例患者选择阿普唑仑的治疗，对比患者的治疗效果。结果实验组患者治疗有效率为90.48%，对照组患者治疗有效率为76.47%。两组患者的治疗效果差异有统计学意义（P<0.05）。结论神经衰弱患者采用阿普唑仑和天麻素的综合治疗，能够缓解头痛、头晕等情况，治疗失眠，并改善抑郁和焦虑的症状。
目的：探究神經衰弱患者採用阿普唑崙和天痳素的綜閤治療的方法和效果。方法選取2013年5月～2014年7月收治的38例神經衰弱患者進行治療，隨機分組，實驗組21例患者阿普唑崙和天痳素的綜閤治療，對照組17例患者選擇阿普唑崙的治療，對比患者的治療效果。結果實驗組患者治療有效率為90.48%，對照組患者治療有效率為76.47%。兩組患者的治療效果差異有統計學意義（P<0.05）。結論神經衰弱患者採用阿普唑崙和天痳素的綜閤治療，能夠緩解頭痛、頭暈等情況，治療失眠，併改善抑鬱和焦慮的癥狀。
목적：탐구신경쇠약환자채용아보서륜화천마소적종합치료적방법화효과。방법선취2013년5월～2014년7월수치적38례신경쇠약환자진행치료，수궤분조，실험조21례환자아보서륜화천마소적종합치료，대조조17례환자선택아보서륜적치료，대비환자적치료효과。결과실험조환자치료유효솔위90.48%，대조조환자치료유효솔위76.47%。량조환자적치료효과차이유통계학의의（P<0.05）。결론신경쇠약환자채용아보서륜화천마소적종합치료，능구완해두통、두훈등정황，치료실면，병개선억욱화초필적증상。
Objective Comprehensive treatment approach and effect of alprazolam combined with gastrodin in treatment of neurasthenia are investigated. Methods Chose 38 neurasthenia patients who were treated in hospital from May 2013 to July 2014 and separated them into two groups at random. 21 patients in study group were given comprehensive treatment of alprazolam combined with gastrodin,while 17 patients in control group were given alprazolam treatment only,and then observed and compared treatment efficacy of the two groups. Results The treatment efficacy in study group was 90.48%; while treatment efficacy in control group was 76.47%; there was a treatment efficacy differential between the two groups,and such a differential had statistic value(P<0.05). Conclusion Alprazolam combined with gastrodin is of efficacy in treatment of neurasthenia; it is conducive to relieving symptoms of headache and dizziness to cure insomnia; and in addition,such a treatment approach is effective to improve symptoms of depression and anxiety.
